Landfar Bio-medicine Co., Ltd

¥7.99As of Sun 8 Nov 2026, 12:00 UTC
SZSE:000504Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (6.30%)
Div yield 0.29%
ROE 1.85%
Biotechnology
Beta (5Y) 0.53
PE TTM 120.4
TSR TTM (16.51%)
Mkt cap ¥2.637B
ROIC 1.73%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥9.65
20.73%
(21.89%)
Hold 5|8|12|12|3
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.20
0.21
0.21
0.20
40.95%
32.99%
19.86%
3.61%
Revenue¥M
198.8
194.1
204.5
209.7
5.13%
(0.21%)
1.37%
6.36%
Peers (US$395.3M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.028
0.468
0.302
EBIT/Intx
4.538
0.390
0.384
Own earn%
(45.31)
130.34
106.10
Sh yield%
31.09
50.28
51.06
Owners
Insiders/Inst%
10.23
43.42
Short interest%
5.28
SBC / revenue%
4.85
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
22–28
$1 testx
−0.1
Incr. ROIC%
−1